influenzae. Furthermore, it is 78% similar selleck chemicals to the Hfq protein from E. coli and all residues that contribute to RNA binding in the latter species are conserved (Figure  1A) [44]. By comparison with HI0411, the Hfq protein in E. coli contains a longer C terminal extension. This C terminal extension is highly variable among different species of bacteria and does not contribute to the overall activity of Hfq [45]. The hfq gene is located on the lagging strand of the Rd KW20 genome and is downstream of the tyrR gene (encoding a transcriptional regulatory protein) and upstream of HI0412 (encoding 23S rRNA pseudouridylate synthase C). These same two genes also flank hfq in the H. influenzae strains used in

the remainder of this study. The hfq gene is highly conserved among all sequenced strains of H. influenzae, an indication that this gene serves an important function in this species. This would suggest that H. influenzae also uses Hfq along

with sRNAs to modulate gene expression, Selleck PF-6463922 the posited role for Hfq in other prokaryotes. Figure 1 Characterization of the hfq gene in H. influenzae . (A) CLUSTALW alignment between the Hfq of E. coli (Hfq_Ec) and H. influenzae. Amino acids denoted by asterisks (*) are identical, colons (:) strongly similar and dots (.) weakly similar. The secondary structure of the E. coli Hfq is indicated above the sequence and dashed-line boxes denote the Sm1 and Sm2 motifs. The shaded boxes are residues that are important in RNA binding by the

Hfq of S. aureus and the two signature motifs of Hfq are underlined. This was modified from the figure of Nielson et al. [44]. (B) Fluorescent intensities of primer extension products synthesized from H. influenzae RNA. (C) Sequence of the transcription start site (+1) and the proposed promoter region for the H. influenzae Hfq gene. The sequence complementary to the primer used for primer extension is boxed, the transcription start site is boldfaced, and the putative −10 and −35 promoter sequences are underlined. Nontypeable H. influenzae strains R2866 and 86-028NP were selected for the studies cAMP inhibitor described herein since both strains have each been well characterized both genetically and phenotypically. Both strains have also been extensively used in the animal models described herein [22, 29, 41, 46–48]. Rd KW20 was not used for further study because it is considered an avirulent ‘laboratory strain’ of H. influenzae since it has lost the genes that encode the type d capsule and lacks adhesins that are necessary for nontypeable H. influenzae disease [49, 50]. In several organisms the hfq gene is co-transcribed with the upstream gene miaA when that gene is present [51, 52]. However, in bacterial species in which a gene other than miaA is upstream, hfq is not co-transcribed [53]. RT-PCR experiments performed in R2866 and 86-028NP indicated that hfq is not co-transcribed with either of the CB-5083 in vivo flanking genes (data not shown).